Cargando…
单倍型造血干细胞移植治疗26例复发难治侵袭性非霍奇金淋巴瘤疗效和安全性研究
OBJECTIVE: To explore the efficacy and safety of haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) for refractory, relapsed or highly aggressive non-Hodgkin lymphoma (NHL) patients. METHODS: A total of 26 patients with refractory, relapsed or highly aggressive NHL who received Hapl...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348539/ https://www.ncbi.nlm.nih.gov/pubmed/27587245 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.005 |
Ejemplares similares
-
PD-1抑制剂治疗复发或难治性经典型霍奇金淋巴瘤的疗效和安全性分析
Publicado: (2023) -
IGEV方案治疗复发难治性霍奇金淋巴瘤的临床研究
Publicado: (2018) -
新免疫治疗时代下复发难治性霍奇金淋巴瘤治疗新策略
Publicado: (2019) -
Brentuximab vedotin联合氮芥治疗六例复发难治性霍奇金淋巴瘤疗效分析
Publicado: (2015) -
复发/难治性非霍奇金淋巴瘤CAR-T细胞治疗后的复发机制及应对策略
Publicado: (2020)